Literature DB >> 28605742

Endotoxin Exposure Increases LL-37 - but Not Calprotectin - in Healthy Human Airways.

Margaretha E Smith1, Marit Stockfelt, Sara Tengvall, Peter Bergman, Anders Lindén, Ingemar Qvarfordt.   

Abstract

RATIONALE: The antimicrobial peptides (AMPs) LL-37 and calprotectin are important players in the innate immunity of human airways. In patients with diseases characterized by bacterial colonization, the airway concentrations of these AMPs are increased. Less is known about their presence and release patterns in healthy humans. Our aim was to determine whether LL-37 and calprotectin are released after the activation of the innate immune response in the peripheral airways.
METHODS: Healthy volunteers underwent exposure to endotoxin and vehicle in contralateral segment bronchi. After 12 or 24 h, samples of bronchoalveolar lavage fluid (BALf) were collected bilaterally from exposed segments. Cell and AMP concentrations were assessed, as were the pro-form and active form of LL-37.
RESULTS: Both LL-37 and calprotectin were detected in cell-free BALf from both endotoxin- and vehicle-exposed segments. The concentrations of precursor and active LL-37 and neutrophils were significantly higher in endotoxin-exposed segments after 12 and 24 h, and the concentrations of LL-37 and neutrophils correlated positively. The concentrations of calprotectin were not markedly affected by exposure to endotoxin.
CONCLUSIONS: Local endotoxin exposure elicits the release and activation of LL-37 but not calprotectin in healthy human peripheral airways, suggesting an inducible involvement of LL-37 in the local innate immune response.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Bronchoalveolar lavage fluid; Calprotectin; Endotoxin; LL-37; Lipopolysaccharide; Lung; Neutrophils

Mesh:

Substances:

Year:  2017        PMID: 28605742      PMCID: PMC6738871          DOI: 10.1159/000475525

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  25 in total

1.  Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense.

Authors:  Hiroyuki Yoshio; Maria Tollin; Gudmunder H Gudmundsson; Hugo Lagercrantz; Hans Jornvall; Giovanna Marchini; Birgitta Agerberth
Journal:  Pediatr Res       Date:  2003-02       Impact factor: 3.756

Review 2.  Impact of LL-37 on anti-infective immunity.

Authors:  Dawn M E Bowdish; Donald J Davidson; Y Elaine Lau; Ken Lee; Monisha G Scott; Robert E W Hancock
Journal:  J Leukoc Biol       Date:  2004-11-29       Impact factor: 4.962

3.  Local inflammatory responses following bronchial endotoxin instillation in humans.

Authors:  N P O'Grady; H L Preas; J Pugin; C Fiuza; M Tropea; D Reda; S M Banks; A F Suffredini
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

4.  Synergistic and additive killing by antimicrobial factors found in human airway surface liquid.

Authors:  P K Singh; B F Tack; P B McCray; M J Welsh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-11       Impact factor: 5.464

5.  Activity of cecropin P1 and FA-LL-37 against urogenital microflora.

Authors:  V Smeianov; K Scott; G Reid
Journal:  Microbes Infect       Date:  2000-06       Impact factor: 2.700

6.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

7.  Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3.

Authors:  O E Sørensen; P Follin; A H Johnsen; J Calafat; G S Tjabringa; P S Hiemstra; N Borregaard
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

8.  Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification.

Authors:  Dietrich Merkel; Wolfgang Rist; Peter Seither; Andreas Weith; Martin C Lenter
Journal:  Proteomics       Date:  2005-07       Impact factor: 3.984

9.  Induction of calprotectin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils.

Authors:  J Kido; R Kido; M Kataoka; M K Fagerhol; T Nagata
Journal:  Oral Microbiol Immunol       Date:  2004-06

10.  LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.

Authors:  Q Chen; A P Schmidt; G M Anderson; J M Wang; J Wooters; J J Oppenheim; O Chertov
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  2 in total

1.  Cathelicidin - A Novel Potential Marker of Pediatric Inflammatory Bowel Disease.

Authors:  Paulina Krawiec; Elżbieta Pac-Kożuchowska
Journal:  J Inflamm Res       Date:  2021-01-22

Review 2.  Calprotectin in Lung Diseases.

Authors:  Ourania S Kotsiou; Dimitrios Papagiannis; Rodanthi Papadopoulou; Konstantinos I Gourgoulianis
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.